DexCom Inc

Stock Chart, Company Information, and Scan Results

$76(as of Sep 11, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

DexCom Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$76
Ticker SymbolDXCM
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees10,200
CountyUSA
Market Cap$29,803.8M
EBIDTA923.3M
10-Day Moving Average77.33
P/E Ratio54.28
20-Day Moving Average78.45
Forward P/E Ratio30.30
50-Day Moving Average81.17
Earnings per Share1.42
200-Day Moving Average80.06
Profit Margin15.54%
RSI42.01
Shares Outstanding392.2M
ATR2.41
52-Week High93.25
Volume6,333,992
52-Week Low57.52
Most Recent Support Level75.56
Book Value2,573.1M
Most Recent Resistance Level81.64
P/B Ratio12.06
Upper Keltner83.88
P/S Ratio7.21
Lower Keltner73.02
Debt-to-Equity Ratio83.88
Next Earnings Date10/30/2025
Cash Surplus-2,149.7M
Next Ex-Dividend DateUnknown

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DexCom Inc In Our Stock Scanner

As of Sep 12, 2025
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Gravestone DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.